Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,810 | 123 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $467.08 | 29 | $0 (2023) |
| Novo Nordisk Inc | $375.19 | 31 | $0 (2024) |
| Lilly USA, LLC | $277.94 | 20 | $0 (2024) |
| EISAI INC. | $136.13 | 11 | $0 (2022) |
| Merck Sharp & Dohme LLC | $87.46 | 5 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $85.58 | 5 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $76.40 | 4 | $0 (2018) |
| Allergan, Inc. | $46.48 | 2 | $0 (2020) |
| Antares Pharma, Inc. | $43.57 | 2 | $0 (2024) |
| Amarin Pharma Inc. | $33.30 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $300.78 | 20 | Lilly USA, LLC ($135.61) |
| 2023 | $277.19 | 16 | ABBVIE INC. ($172.84) |
| 2022 | $620.11 | 45 | ABBVIE INC. ($233.40) |
| 2021 | $407.19 | 30 | Novo Nordisk Inc ($181.44) |
| 2020 | $77.09 | 4 | Allergan, Inc. ($46.48) |
| 2018 | $29.37 | 2 | BOSTON SCIENTIFIC CORPORATION ($18.87) |
| 2017 | $98.18 | 6 | BOSTON SCIENTIFIC CORPORATION ($57.53) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes Care | ||||||
| 07/16/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: PAIN | ||||||
| 06/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Obesity | ||||||
| 05/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: Diabetes | ||||||
| 04/01/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Biological | ||||||
| 03/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 02/08/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: Diabetes | ||||||
| 01/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Obesity | ||||||
| 01/08/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Diabetes | ||||||
| 01/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/25/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Diabetes | ||||||
| 07/24/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 38 | 65 | $7,045 | $4,111 |
| 2022 | 5 | 190 | 229 | $34,015 | $9,205 |
| 2021 | 19 | 1,369 | 3,107 | $310,304 | $121,108 |
| 2020 | 24 | 2,148 | 4,556 | $428,024 | $148,998 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 51 | $6,835 | $3,994 | 58.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 14 | $210.00 | $117.60 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 122 | $23,273 | $6,643 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 46 | $6,658 | $1,905 | 28.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 15 | 15 | $2,250 | $406.20 | 18.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 18 | 18 | $558.00 | $174.78 | 31.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 28 | $1,276 | $76.02 | 6.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 367 | 575 | $127,650 | $46,122 | 36.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 11 | 960 | $30,720 | $15,590 | 50.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 120 | 120 | $27,840 | $14,620 | 52.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 187 | 227 | $34,263 | $14,144 | 41.3% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 74 | 74 | $14,430 | $5,454 | 37.8% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 23 | 25 | $11,950 | $5,232 | 43.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 56 | 56 | $6,395 | $3,650 | 57.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 58 | 66 | $9,900 | $2,497 | 25.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 40 | 83 | $9,462 | $2,309 | 24.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 48 | 52 | $8,372 | $2,205 | 26.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 43 | 229 | $11,728 | $2,055 | 17.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 112 | 112 | $4,256 | $1,932 | 45.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 13 | $3,874 | $1,818 | 46.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 86 | 154 | $4,774 | $1,476 | 30.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 67 | 67 | $2,010 | $1,038 | 51.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $1,170 | $632.60 | 54.1% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 12 | 12 | $275.01 | $205.30 | 74.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 27 | 138 | $1,104 | $116.14 | 10.5% |
About Dr. Warren Hancock, DO
Dr. Warren Hancock, DO is a Family Medicine healthcare provider based in Claremore, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2011. The National Provider Identifier (NPI) number assigned to this provider is 1902196728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Warren Hancock, DO has received a total of $1,810 in payments from pharmaceutical and medical device companies, with $300.78 received in 2024. These payments were reported across 123 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,810).
As a Medicare-enrolled provider, Hancock has provided services to 3,745 Medicare beneficiaries, totaling 7,957 services with total Medicare billing of $283,422. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Claremore, OK
- Active Since 04/13/2011
- Last Updated 11/19/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902196728
Products in Payments
- UBRELVY (Drug) $200.07
- QULIPTA (Drug) $176.63
- Ozempic (Drug) $164.30
- VRAYLAR (Drug) $136.86
- Dayvigo (Drug) $136.13
- MOUNJARO (Drug) $94.11
- TRINTELLIX (Drug) $85.58
- Rybelsus (Drug) $74.39
- BELSOMRA (Drug) $74.32
- TRULICITY (Drug) $73.49
- NURTEC ODT (Drug) $69.57
- Saxenda (Drug) $66.76
- XYOSTED (Drug) $63.97
- JARDIANCE (Drug) $56.95
- Wegovy (Drug) $55.32
- EMBOZENE (Device) $39.40
- EMGALITY (Drug) $39.32
- Vascepa (Drug) $33.30
- CONTRAVE (Drug) $27.78
- DIREXION (Device) $19.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Claremore
Dr. Brent Hinkle, D.o, D.O
Family Medicine — Payments: $15,112
Dr. Seth Nodine, Md, MD
Family Medicine — Payments: $14,679
Dr. Andrew Sperling, D.o, D.O
Family Medicine — Payments: $14,639
Dr. Jeffrey Williams, D.o, D.O
Family Medicine — Payments: $13,050
Christen Greuel, D.o, D.O
Family Medicine — Payments: $6,854
Ashley Bridges
Family Medicine — Payments: $5,694